[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ark Genomic Revolution ETF (ARKG)

Ark Genomic Revolution ETF (ARKG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Ark Funds
  • Assets Under Management 1,185,672,000
  • Shares Outstanding, K 38,900
  • 60-Month Beta 1.72
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.382 on 12/29/21
  • Management Fee 0.75%
  • INDUSTRY GROUPING:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 44.05% (+2.35%)
  • Historical Volatility 44.52%
  • IV Percentile 40%
  • IV Rank 39.93%
  • IV High 70.45% on 10/13/25
  • IV Low 26.49% on 07/22/25
  • Expected Move (DTE 5) 1.32 (4.32%)
  • Put/Call Vol Ratio 0.50
  • Today's Volume 2,249
  • Volume Avg (30-Day) 15,463
  • Put/Call OI Ratio 0.66
  • Today's Open Interest 194,130
  • Open Int (30-Day) 189,960
  • Expected Range 29.16 to 31.80

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.35 +15.67%
on 04/10/26
31.86 -4.33%
on 04/21/26
+2.67 (+9.60%)
since 04/08/26
3-Month
24.60 +23.90%
on 03/30/26
31.86 -4.33%
on 04/21/26
+1.69 (+5.87%)
since 02/06/26
52-Week
20.26 +50.42%
on 05/23/25
34.39 -11.37%
on 01/22/26
+8.75 (+40.27%)
since 05/08/25

Most Recent Stories

More News
Intellia Therapeutics Stock Is Down Nearly 95% From Its Record Highs but Cathie Wood Keeps Buying

Despite Intellia's severe stock drop from its 2021 peak, Cathie Wood is buying big.

ARKG : 30.48 (+0.33%)
REGN : 714.89 (+0.82%)
NTLA : 14.09 (+2.77%)
ARKK : 79.12 (+1.53%)
Cathie Wood Is Buying Up Alamar Biosciences Stock After Its IPO. Should You Snag Proteomics-Focused ALMR Too?

While Cathie Wood’s involvement adds visibility, market sentiment remains mixed on whether ALMR offers sustainable upside at current valuation levels.

ARKG : 30.48 (+0.33%)
ALMR : 23.96 (+1.27%)
Cathie Wood Adds 48K Shares to This Under-the-Radar Growth Play

Wood trimmed stakes in Nvidia, Meta, and Tesla; instead, she added this speculative biotech play.

NVDA : 215.20 (+1.75%)
META : 609.63 (-1.16%)
TSLA : 428.35 (+4.02%)
ARKG : 30.48 (+0.33%)
$SPX : 7,398.93 (+0.84%)
AMD : 455.19 (+11.44%)
ARCT : 9.22 (+3.60%)
MRNA : 54.35 (+11.97%)
This Cathie Wood Stock Is Down 36% Over the Past 2 Years. She Still Can’t Get Enough.

Cathie Wood recently added to her position in CRISPR Therapeutics stock.

CRSP : 54.83 (+4.60%)
ARKG : 30.48 (+0.33%)
ARKK : 79.12 (+1.53%)
Cathie Wood Bets $19 Million on 5 Beaten-Down Stocks

Cathie Woods’s ARK Invest deploys $19 million across five growth stocks in this uncertain market.

DKNG : 25.52 (+1.19%)
ARKF : 42.26 (-0.05%)
CMPS : 9.91 (+5.54%)
ARKW : 146.89 (+0.77%)
ARKG : 30.48 (+0.33%)
CNTN : 3.02 (+1.34%)
CERS : 2.61 (unch)
HOOD : 77.03 (+0.98%)
ARKK : 79.12 (+1.53%)
How to Invest in the New Era of Agentic AI for Biotech Stocks

Our senior market strategist explains which ETFs offer exposure to high-powered biotech growth, without T. Rex-sized risk.

ARKG : 30.48 (+0.33%)
IBB : 169.94 (-0.09%)
XBI : 134.71 (+0.79%)
Cathie Wood Is Doubling Down on Recursion Pharmaceuticals Stock. Should You Buy RXRX Here?

Cathie Wood is resolute on RXRX despite its slump. Should investors follow her lead into this AI-driven biotech bet now?

ARKG : 30.48 (+0.33%)
RXRX : 3.32 (+1.53%)
ARKK : 79.12 (+1.53%)
Why Cathie Wood is Loading Up on These 2 Growth Stocks (And Should You?)

These two companies fit the type of transformative growth story Cathie Wood seeks out.

ARKW : 146.89 (+0.77%)
ARKG : 30.48 (+0.33%)
RBRK : 62.34 (+1.38%)
PRME : 3.21 (+3.05%)
Why Cathie Wood Is Loading Up on This Hot Growth Stock (And Should You?)

This dip in Illumina’s stock could be an attractive opportunity for long-term growth investors.

ARKG : 30.48 (+0.33%)
ILMN : 141.88 (+2.29%)
BMO Announces Final Valuations and Declares Final Distributions on Units of ETF Series of Terminated BMO Mutual Funds

/CNW/ - BMO Investments Inc. ("BMOII") today announced the final net asset values for the ETF Series of each of BMO ARK Genomic Revolution Fund (Cboe Canada:...

ARKG : 30.48 (+0.33%)
ARKW : 146.89 (+0.77%)
BMO : 152.90 (+0.28%)
ARKK : 79.12 (+1.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The ARK Genomic Revolution ETF seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials,...

See More

Key Turning Points

3rd Resistance Point 32.04
2nd Resistance Point 31.29
1st Resistance Point 30.88
Last Price 30.48
1st Support Level 29.72
2nd Support Level 28.97
3rd Support Level 28.56

See More

52-Week High 34.39
Last Price 30.48
Fibonacci 61.8% 28.99
Fibonacci 50% 27.33
Fibonacci 38.2% 25.66
52-Week Low 20.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.